Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV003277199 | SCV003984437 | uncertain significance | Inborn genetic diseases | 2023-05-17 | criteria provided, single submitter | clinical testing | The c.11213G>C (p.S3738T) alteration is located in exon 9 (coding exon 9) of the FAT4 gene. This alteration results from a G to C substitution at nucleotide position 11213, causing the serine (S) at amino acid position 3738 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005029964 | SCV005657570 | uncertain significance | Van Maldergem syndrome 2; Hennekam lymphangiectasia-lymphedema syndrome 2 | 2024-04-14 | criteria provided, single submitter | clinical testing |